166 related articles for article (PubMed ID: 16134004)
1. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome.
Kasperska-Zajac A; Nowakowski M; Rogala B
Inflammation; 2004 Oct; 28(5):299-302. PubMed ID: 16134004
[TBL] [Abstract][Full Text] [Related]
2. Enhanced release of platelet factor 4 into the circulation in patients with atopic eczema/dermatitis syndrome.
Kasperska-Zajac A; Rogala B; Nowakowski M
Rocz Akad Med Bialymst; 2003; 48():128-30. PubMed ID: 14737958
[TBL] [Abstract][Full Text] [Related]
3. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Allergol Int; 2008 Dec; 57(4):391-6. PubMed ID: 18797178
[TBL] [Abstract][Full Text] [Related]
4. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure.
Kasperska-Zajac A; Rogala B
Inflamm Res; 2003 Nov; 52(11):477-9. PubMed ID: 14652682
[TBL] [Abstract][Full Text] [Related]
5. [Platelet factor 4 and β-thromboglobulin in blood plasma of patients with acute exacerbation of chronic obstructive pulmonary disease].
Wu JF; Yang YH; Pang BS
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1378-82. PubMed ID: 24025501
[TBL] [Abstract][Full Text] [Related]
6. Recovery of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG) plasma concentrations during remission in patients suffering from atopic dermatitis.
Kasperska-Zajac A
Platelets; 2010; 21(7):522-4. PubMed ID: 20670105
[TBL] [Abstract][Full Text] [Related]
7. Platelet activity in cluster headache.
D'Andrea G; Cananzi AR; Toldo M; Ferro-Milone F
Cephalalgia; 1986 Sep; 6(3):163-7. PubMed ID: 2945644
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
[TBL] [Abstract][Full Text] [Related]
9. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
10. The evidence of platelet activation in bronchial asthma.
Yamamoto H; Nagata M; Tabe K; Kimura I; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):79-87. PubMed ID: 8423274
[TBL] [Abstract][Full Text] [Related]
11. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
12. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis.
Kowal-Bielecka O; Kowal K; Lewszuk A; Bodzenta-Lukaszyk A; Walecki J; Sierakowski S
Ann Rheum Dis; 2005 Mar; 64(3):484-6. PubMed ID: 15708900
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR) in patients with atopic eczema/dermatitis syndrome.
Kasperska-Zajac A; Rogala B
Inflammation; 2005 Apr; 29(2-3):90-3. PubMed ID: 16858643
[TBL] [Abstract][Full Text] [Related]
14. [The changes in plasma beta-thromboglobulin (beta-TG), platelet factor 4 (PF4) and thromboxane B2 (TXB2) after a bronchial provocation test (BPT) with house dust (HD) allergen].
Mizuno M; Adachi M; Maruyama S; Suganuma T; Okada T; Takahashi T
Arerugi; 1991 May; 40(5):500-5. PubMed ID: 1831967
[TBL] [Abstract][Full Text] [Related]
15. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
16. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis.
Cananzi AR; Ferro-Milone F; Grigoletto F; Toldo M; Meneghini F; Bortolon F; D'Andrea G
Acta Neurol Scand; 1987 Aug; 76(2):79-85. PubMed ID: 2960124
[TBL] [Abstract][Full Text] [Related]
17. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.
Bellon JL; Castellanos C; Acevedo L; Amiral J
Semin Thromb Hemost; 1993; 19 Suppl 1():178-82. PubMed ID: 8362264
[TBL] [Abstract][Full Text] [Related]
18. Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype.
Leonardi S; Cuppari C; Manti S; Filippelli M; Parisi GF; Borgia F; Briuglia S; Cannavò P; Salpietro A; Arrigo T; Salpietro C
Allergy Asthma Proc; 2015; 36(1):74-81. PubMed ID: 25562560
[TBL] [Abstract][Full Text] [Related]
19. Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status.
Adamek-Guzik T; Guzik TJ; Czerniawska-Mysik G; Korpanty G; Mastalerz L; Radwan J; Szczeklik A
Allergy; 2002 Aug; 57(8):732-6. PubMed ID: 12121194
[TBL] [Abstract][Full Text] [Related]
20. IgE values and T-lymphocyte subsets in children with atopic eczema/dermatitis syndrome.
Leonardi S; Rotolo N; Vitaliti G; Spicuzza L; La Rosa M
Allergy Asthma Proc; 2007; 28(5):529-34. PubMed ID: 18034970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
